Anthropology of Deep Brain Stimulation; the 30th Anniversary of STN DBS in 2023.
Parkinson's disease
anthropology
deep brain stimulation
movement disorders
subthalamic nucleus
Journal
Movement disorders clinical practice
ISSN: 2330-1619
Titre abrégé: Mov Disord Clin Pract
Pays: United States
ID NLM: 101630279
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
14
06
2023
revised:
13
07
2023
accepted:
15
07
2023
medline:
29
9
2023
pubmed:
29
9
2023
entrez:
29
9
2023
Statut:
epublish
Résumé
The year 2023 marks the 30th anniversary of deep brain stimulation (DBS) of the subthalamic nucleus (STN) for Parkinson To study the anthropology of DBS, that is, its ethno-geographic origins, its evolution, its impact on clinicians and scientists, and its influence on society at large. The authors scrutinized the geo-ethnic origins of the pioneers of modern DBS, and they evaluated, based on the literature and on a long-term praxis, the development of DBS and its impact on clinicians, on healthcare, and on society. Scientists and clinicians from various geo-ethnic origins pioneered modern DBS, leading to worldwide spread of this procedure and to the establishment of large multidisciplinary teams in many centers. Neurologists became actively involved in surgery and took on new laborious tasks of programming ever more complicated DBS systems. Publications sky-rocketed and the global spread of DBS impacted positively on several aspects of society, including healthcare, awareness of neurological diseases, interdisciplinary relations, conferences, patient organizations, unemployment, industry, etc. STN DBS has boosted the field of deep brain electrotherapy for many neurological and psychiatric illnesses, and DBS has generated a global benefit on many aspects of society, well beyond its clinical benefits on symptoms of diseases. With the ever-increasing indications for DBS, more positive global impact is expected.
Sections du résumé
Background
UNASSIGNED
The year 2023 marks the 30th anniversary of deep brain stimulation (DBS) of the subthalamic nucleus (STN) for Parkinson
Objective
UNASSIGNED
To study the anthropology of DBS, that is, its ethno-geographic origins, its evolution, its impact on clinicians and scientists, and its influence on society at large.
Material and Methods
UNASSIGNED
The authors scrutinized the geo-ethnic origins of the pioneers of modern DBS, and they evaluated, based on the literature and on a long-term praxis, the development of DBS and its impact on clinicians, on healthcare, and on society.
Results
UNASSIGNED
Scientists and clinicians from various geo-ethnic origins pioneered modern DBS, leading to worldwide spread of this procedure and to the establishment of large multidisciplinary teams in many centers. Neurologists became actively involved in surgery and took on new laborious tasks of programming ever more complicated DBS systems. Publications sky-rocketed and the global spread of DBS impacted positively on several aspects of society, including healthcare, awareness of neurological diseases, interdisciplinary relations, conferences, patient organizations, unemployment, industry, etc.
Conclusions
UNASSIGNED
STN DBS has boosted the field of deep brain electrotherapy for many neurological and psychiatric illnesses, and DBS has generated a global benefit on many aspects of society, well beyond its clinical benefits on symptoms of diseases. With the ever-increasing indications for DBS, more positive global impact is expected.
Identifiants
pubmed: 37772285
doi: 10.1002/mdc3.13858
pii: MDC313858
pmc: PMC10525058
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1285-1292Informations de copyright
© 2023 The Authors. Movement Disorders Clinical Practice published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Références
Ann Neurol. 1996 Sep;40(3):341-3
pubmed: 8797522
Mov Disord Clin Pract. 2016 Mar 31;3(3):288-291
pubmed: 30363553
Front Hum Neurosci. 2023 Jan 27;16:1084782
pubmed: 36819295
Mov Disord Clin Pract. 2016 Feb 11;3(3):285-287
pubmed: 30363426
Mov Disord. 2015 Sep;30(10):1407-13
pubmed: 26184453
Stereotact Funct Neurosurg. 2023;101(2):112-134
pubmed: 36809747
Science. 1947 Oct 10;106(2754):349-50
pubmed: 17777432
Parkinsonism Relat Disord. 2014 Jul;20(7):731-7
pubmed: 24768120
Rev Neurol (Paris). 1993;149(3):175-6
pubmed: 8235208
Eur J Neurosci. 1993 Apr 1;5(4):382-9
pubmed: 8261116
J Parkinsons Dis. 2017;7(s1):S33-S41
pubmed: 28282816
Mov Disord. 2003 Aug;18(8):845-53
pubmed: 12889073
Mov Disord. 2013 Oct;28(12):1640-1
pubmed: 23857820
Brain. 2012 Jul;135(Pt 7):2006-21
pubmed: 22334584
J Neurosurg. 2022 Aug 05;138(4):1028-1033
pubmed: 35932269
Lancet. 1999 Oct 30;354(9189):1526
pubmed: 10551504
Handb Clin Neurol. 2013;116:63-71
pubmed: 24112885
N Engl J Med. 2013 Feb 14;368(7):610-22
pubmed: 23406026
Parkinsonism Relat Disord. 2015 Mar;21(3):345-6
pubmed: 25443552
Lancet. 1999 Feb 27;353(9154):724
pubmed: 10073521
Science. 1990 Sep 21;249(4975):1436-8
pubmed: 2402638
Trends Cogn Sci. 2009 Nov;13(11):479-87
pubmed: 19782634
Neurochirurgie. 1999 May;45(2):139-44
pubmed: 10448655
BMJ. 2012 Aug 13;345:e5447
pubmed: 22890031
Stereotact Funct Neurosurg. 2022;100(3):184-197
pubmed: 35104819
Mov Disord. 1991;6(4):288-92
pubmed: 1758446
Neurosurg Clin N Am. 2023 Apr;34(2):291-299
pubmed: 36906335
N Engl J Med. 2001 Sep 27;345(13):956-63
pubmed: 11575287
N Engl J Med. 1998 Oct 15;339(16):1105-11
pubmed: 9770557
J Intern Med. 2022 Nov;292(5):764-778
pubmed: 35798568
Neurosurg Focus. 2013 Nov;35(5):E5
pubmed: 24175865
Appl Neurophysiol. 1987;50(1-6):344-6
pubmed: 3329873
Appl Neurophysiol. 1980;43(3-5):244-58
pubmed: 6975064
J Neurosurg. 1992 Jan;76(1):53-61
pubmed: 1727169
Adv Neurol. 2001;86:455-60
pubmed: 11554009
Stereotact Funct Neurosurg. 2018;96(4):274-275
pubmed: 30134250
Artif Organs. 2009 Mar;33(3):208-20
pubmed: 18684199
J Neurosurg. 2000 Apr;92(4):615-25
pubmed: 10761650
Neurosurgery. 1994 Dec;35(6):1126-9; discussion 1129-30
pubmed: 7885558
Mov Disord. 1998;13 Suppl 1:73-82
pubmed: 9613722
Brain. 1994 Aug;117 ( Pt 4):877-97
pubmed: 7922472
Neurosurg Focus. 2010 Aug;29(2):E1
pubmed: 20672911
Mov Disord. 2001 Jan;16(1):166-8
pubmed: 11215582
Neurology. 1999 Sep 11;53(4):871-4
pubmed: 10489059
J Neural Transm Suppl. 2006;(70):409-14
pubmed: 17017560
Lancet. 1999 Sep 4;354(9181):837-8
pubmed: 10485734